Search results for JAK3

JAK3 antibody [5H2], Genetex, GTX83303

JAK3 Primary Antibody, ProMab, 20400

JAK3, Janus kinase 3. It is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease).

Tyrosine-Protein Kinase JAK3 Phospho-Tyr785 (JAK3 pY785) Antibody, Abbexa, abx329009

Tyrosine-Protein Kinase JAK3 Phospho-Tyr785 (JAK3 pY785) Antibody is a Rabbit Polyclonal against Tyrosine-Protein Kinase JAK3 Phospho-Tyr785 (JAK3 pY785).

Jak3 (pY980 / 981) Antibody, Abbexa, abx123304

Jak3 (pY980/981) Antibody is a Rabbit Polyclonal Antibody against Jak3 (pY980/981).

Phospho-JAK3 (Tyr785) Antibody, Covalab, Ref 00120210

JAK3 Rabbit pAb- ABclonal, ABclonal, A0748

Anti-JAK3 Antibody (R3M78), AntibodySystem, RHE91801

Anti-JAK3 antibody [EP909Y], Abcam, AB45141

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-JAK3 Polyclonal Antibody, AntibodySystem, PHE91801

PE Anti-JAK3 antibody [EP909Y], Abcam, AB306063

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .